Gapicomine
Clinical data | |
---|---|
Routes of administration | oral (tablet) |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C12H13N3 |
Molar mass | 199.25 g/mol |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Gapicomine (INN) is a coronary vasodilator. It has been withdrawn from the market in the countries it was used in.[1]
Also, gapicomine is a major component in the drug bicordin.[2]
History
Gapicomine was discovered in 1970 by Polish chemist Stanisław Biniecki. It was first published about in an article of The Polish Journal of Medicine and Pharmacy describing the derivative drug bicordin in 1974.[3]
References
- ↑ "Gapicomine Monograph, The Index Nominum". Retrieved 2008-03-31.
- ↑ "Bicordin, PubChem". Retrieved 2008-03-31.
- ↑ Samochowiec L, Wójcicki J, Gregorczyk K, Szmatloch E. (1974). "Bicordin--a new drug in the treatment of coronary heart disease". Mater Med Pol.: 298–300. PMID 4453155.
Categories:
- Pages with script errors
- CS1 maint: Multiple names: authors list
- Pages using duplicate arguments in template calls
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Articles containing unverified chemical infoboxes
- Pyridines
- Vasodilators